Vetoquinol Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Vetoquinol SA
Access all reports
Vetoquinol SA is a French veterinary pharmaceutical company that focuses on the development, production, and marketing of veterinary drugs and non-medicinal products. The company provides a diverse range of products aimed at improving the health of companion animals, such as dogs and cats, as well as livestock including cattle and pigs. Vetoquinol's product offerings cover various therapy areas like pain management, mobility, inflammation, dermatology, udder health, anti-parasite solutions, and cardiology among others. The company is headquartered in Lure, France, and its shares are listed on the Euronext Paris.
Key slides for Vetoquinol SA
H1 2024
Vetoquinol SA
H1 2024
Vetoquinol SA
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
VETO
Country
🇫🇷 France